TCG Crossover Management, LLC Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$1.2B
Holdings
36
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY, INC. | 3,670,206 | $138.5T | 11732275.76% | |
| 2 | DYNDYNE THERAPEUTICS, INC | 2,650,150 | $95.2T | 8065137.97% | |
| 3 | COGTCOGENT BIOSCIENCES INC | 6,964,375 | $75.2T | 6372515.79% | |
| 4 | ABVXAbivax SA | 6,056,596 | $69.8T | 5911342.22% | |
| 5 | EWTXEDGEWISE THERAPEUTICS, INC. | 2,112,984 | $56.4T | 4778040.20% | |
| 6 | SLNSILENCE THERAPEUTICS PLC | 3,033,560 | $55.2T | 4672523.42% | |
| 7 | YB4PSAVARA INC. | 12,362,205 | $52.4T | 4440857.25% | |
| 8 | KROSKEROS THERAPEUTICS, INC. | 879,344 | $51.1T | 4326290.19% | |
| 9 | XNCRXENCOR INC | 2,427,138 | $48.8T | 4135343.18% | |
| 10 | TYRATYRA BIOSCIENCES INC | 1,989,103 | $46.8T | 3962004.12% | |
| 11 | GPCRSTRUCTURE THERAPEUTICS INC | 1,063,000 | $46.7T | 3952791.10% | |
| 12 | OCULOCULAR THERAPEUTIX, INC. | 5,319,148 | $46.3T | 3920724.69% | |
| 13 | CNTACENTESSA PHARMACEUTICALS PLC | 2,890,816 | $46.2T | 3916281.78% | |
| 14 | TRMLTOURMALINE BIO INC | 1,477,593 | $38.0T | 3218562.29% | |
| 15 | THRDTHIRD HARMONIC BIO INC | 2,415,000 | $32.7T | 2772435.48% | |
| 16 | CATBUSDASTRIA THERAPEUTICS, INC. | 2,761,861 | $30.4T | 2576286.51% | |
| 17 | MLYSMINERALYS THERAPEUTICS, INC. | 2,470,265 | $29.9T | 2534502.38% | |
| 18 | KURAKURA ONCOLOGY INC | 1,423,642 | $27.8T | 2356841.48% | |
| 19 | SLNOSOLENO THERAPEUTIVS, INC. | 550,000 | $27.8T | 2352735.35% | |
| 20 | CMPSCOMPASS PATHWAYS PLC | 3,858,000 | $24.3T | 2059243.91% | |
| 21 | IRONDisc Medicine, Inc. | 486,957 | $23.9T | 2027359.58% | |
| 22 | FULCFULCRUM THERAPEUTICS INC | 5,250,000 | $18.7T | 1587934.33% | |
| 23 | MBXMBX BIOSCIENCES INC | 650,000 | $16.9T | 1430729.46% | |
| 24 | AMLXAMYLYX PHARMACEUTICALS INC | 4,643,812 | $15.0T | 1274748.94% | |
| 25 | AVU0ADVERUM BIOTECHNOLOGIES, INC. | 2,008,339 | $14.1T | 1194480.76% | |
| 26 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $9.3T | 791961.84% | |
| 27 | VTGNVISTAGEN THERAPEUTICS INC | 2,676,580 | $8.1T | 682577.08% | |
| 28 | TARSTARSUS PHARMACEUTICALS, INC. | 231,820 | $7.6T | 645981.09% | |
| 29 | EYPTEyePoint Pharmaceuticals, Inc. | 922,335 | $7.4T | 624367.81% | |
| 30 | NKTREURNEKTAR THERAPEUTICS | 4,000,000 | $5.2T | 440563.34% | |
| 31 | AVTEAEROVATE THERAPEUTICS INC | 2,240,809 | $4.7T | 396785.84% | |
| 32 | AVTXAVALO THERAPEUTICS INC | 483,000 | $4.6T | 388754.79% | |
| 33 | KODKODIAK SCIENCES INC | 1,008,158 | $2.6T | 222932.85% | |
| 34 | ANTXAN2 Therapeutics, Inc. | 1,555,118 | $1.7T | 140978.24% | |
| 35 | VTYXVENTYX BIOSCIENCES, INC | 316,195 | $689.3B | 58400.48% | |
| 36 | CABACABALETTA BIO, INC | 86,795 | $409.7B | 34708.94% |